Anteris Technologies Global Corp (AU:AVR) — Market Cap & Net Worth
Market Cap & Net Worth: Anteris Technologies Global Corp (AVR)
Anteris Technologies Global Corp (AU:AVR) has a market capitalization of $848.00 Million (AU$1.20 Billion) as of June 17, 2026. Listed on the AU stock exchange, this Australia-based company holds position #9799 globally and #245 in its home market, demonstrating a 9.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anteris Technologies Global Corp's stock price AU$13.15 by its total outstanding shares 96849743 (96.85 Million). Review Anteris Technologies Global Corp (AVR) financial obligations to assess the company's total debt and financial obligations.
Anteris Technologies Global Corp Market Cap History: 2015 to 2026
Anteris Technologies Global Corp's market capitalization history from 2015 to 2026. Data shows change from $4.69 Billion to $901.13 Million (-14.04% CAGR).
Anteris Technologies Global Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anteris Technologies Global Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
129.77x
Anteris Technologies Global Corp's market cap is 129.77 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.69 Billion | $14.15 Million | -$24.01 Million | 331.73x | N/A |
| 2016 | $2.47 Billion | $22.32 Million | -$12.31 Million | 110.51x | N/A |
| 2017 | $2.02 Billion | $22.61 Million | -$17.26 Million | 89.41x | N/A |
| 2018 | $424.87 Million | $25.60 Million | -$24.22 Million | 16.60x | N/A |
| 2019 | $685.27 Million | $17.08 Million | -$5.82 Million | 40.13x | N/A |
| 2020 | $256.98 Million | $7.08 Million | -$15.27 Million | 36.30x | N/A |
| 2021 | $888.11 Million | $7.79 Million | -$22.91 Million | 113.99x | N/A |
| 2022 | $1.52 Billion | $4.59 Million | -$44.34 Million | 331.44x | N/A |
| 2023 | $1.31 Billion | $4.11 Million | -$67.33 Million | 319.21x | N/A |
| 2024 | $566.72 Million | $4.37 Million | -$123.26 Million | 129.77x | N/A |
Competitor Companies of AVR by Market Capitalization
Companies near Anteris Technologies Global Corp in the global market cap rankings as of June 17, 2026.
Key companies related to Anteris Technologies Global Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $154.19 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #205 globally with a market cap of $117.85 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #245 globally with a market cap of $103.20 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $154.19 Billion | $88.67 |
| #205 | Stryker Corporation | NYSE:SYK | $117.85 Billion | $307.94 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #245 | Medtronic PLC | NYSE:MDT | $103.20 Billion | $80.38 |
Anteris Technologies Global Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, Anteris Technologies Global Corp's market cap moved from $4.69 Billion to $ 901.13 Million, with a yearly change of -14.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$901.13 Million | +71.67% |
| 2025 | AU$524.92 Million | -7.38% |
| 2024 | AU$566.72 Million | -56.81% |
| 2023 | AU$1.31 Billion | -13.74% |
| 2022 | AU$1.52 Billion | +71.30% |
| 2021 | AU$888.11 Million | +245.60% |
| 2020 | AU$256.98 Million | -62.50% |
| 2019 | AU$685.27 Million | +61.29% |
| 2018 | AU$424.87 Million | -78.98% |
| 2017 | AU$2.02 Billion | -18.06% |
| 2016 | AU$2.47 Billion | -47.45% |
| 2015 | AU$4.69 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Anteris Technologies Global Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $848.00 Million USD |
| MoneyControl | $848.00 Million USD |
| MarketWatch | $848.00 Million USD |
| marketcap.company | $848.00 Million USD |
| Reuters | $848.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anteris Technologies Global Corp
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calci… Read more